Eight participants achieved HBsAg loss at any time.Two participants met criteria for functional cure. Two participants who discontinued NUC ...

New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an ...

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation, a leader in IT, network and AI technologies, announced 24.1 month .

Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

In 2021, the Barcelona university was hit with an attack that knocked systems offline for two weeks, affecting 50,000 users.

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...

KEBILIDI is an adeno-associated virus vector-based gene therapy indicated ... required for KEBILIDI administration. These events included respiratory and cardiac arrest which occurred within 24 hours ...

First-ever FDA approval for gene therapy directly administered to the brain - - Priority review voucher granted - - Broad label including children and adults - - ...

VANCOUVER, BC / ACCESSWIRE / November 12, 2024 / Kingfisher Metals Corp. (TSXV:KFR) (FSE:970) (OTCQB:KGFMF) ("Kingfisher" or the "Company") is ...

Tsingke proudly concluded its participation in BIO-Europe 2024, held from November 4 to 6 in Stockholm, Sweden. As one of the premier global events for the biotechnology, pharmaceutical, and ...

X-Verse’24, hosted by the Xavier’s Commerce and Management Society, aimed to foster professional development and intellectual exchange among students through a series of competitive events The event ...